---
figid: PMC1993933__vhrm0101-029-f1
figtitle: Mevalonate pathway
organisms:
- NA
pmcid: PMC1993933
filename: vhrm0101-029-f1.jpg
figlink: /pmc/articles/PMC1993933/figure/fig1/
number: F1
caption: 'The mevalonate pathway. By inhibiting 3-hydroxy-3-methylglutaryl coenzyme
  A (HMG-CoA) reductase, statins interfere with the synthesis not only of cholesterol
  but also of isoprenoid intermediates, such as geranylgeranyl pyrophosphate (PP),
  which contribute to oxidative stress and cellular proliferation and migration. Inhibition
  of these isoprenoid intermediates may contribute to the pleiotropic effects of statin
  therapy. Abbreviations: FFP, farnesyl pyrophosphate; GPP, geranylgeranyl pyrophosphate;
  IPP, isopentenyl pyrophosphate.'
papertitle: Ongoing Clinical Trials of the Pleiotropic Effects of Statins.
reftext: Jean Davignon, et al. Vasc Health Risk Manag. 2005 Mar;1(1):29-40.
year: '2005'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8326698
figid_alias: PMC1993933__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC1993933__F1
ndex: c5ce0084-df24-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC1993933__vhrm0101-029-f1.html
  '@type': Dataset
  description: 'The mevalonate pathway. By inhibiting 3-hydroxy-3-methylglutaryl coenzyme
    A (HMG-CoA) reductase, statins interfere with the synthesis not only of cholesterol
    but also of isoprenoid intermediates, such as geranylgeranyl pyrophosphate (PP),
    which contribute to oxidative stress and cellular proliferation and migration.
    Inhibition of these isoprenoid intermediates may contribute to the pleiotropic
    effects of statin therapy. Abbreviations: FFP, farnesyl pyrophosphate; GPP, geranylgeranyl
    pyrophosphate; IPP, isopentenyl pyrophosphate.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Ipp
  - CG9784
  - CG9426
  - CG6805
  - Synj
  - INPP5E
  - 5PtaseI
  - gpp
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - rab
  - Rab5
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - KRAS
  - HRAS
  - NRAS
  - IPP
  - MSX2
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - AGFG1
  - RAB10
  - RAB11A
  - RAB11B
  - RAB12
  - RAB13
  - RAB14
  - RAB15
  - RAB17
  - RAB18
  - RAB19
  - RAB1A
  - RAB1B
  - RAB1C
  - RAB20
  - RAB21
  - RAB22A
  - RAB23
  - RAB24
  - RAB25
  - RAB26
  - RAB27A
  - RAB27B
  - RAB28
  - RAB2A
  - RAB2B
  - RAB30
  - RAB31
  - RAB32
  - RAB33A
  - RAB33B
  - RAB34
  - RAB35
  - RAB36
  - RAB37
  - RAB38
  - RAB39A
  - RAB39B
  - RAB3A
  - RAB3B
  - RAB3C
  - RAB3D
  - RAB40A
  - RAB40AL
  - RAB40B
  - RAB40C
  - RAB41
  - RAB42
  - RAB43
  - RAB44
  - RAB4A
  - RAB4B
  - RAB5A
  - RAB5B
  - RAB5C
  - RAB6A
  - RAB6B
  - RAB6C
  - RAB7A
  - RAB7B
  - RAB29
  - RAB8A
  - RAB8B
  - RAB9A
  - RAB9B
  - RABL2A
  - RABL2B
  - RABL3
  - IFT22
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - Isoprene
  - Cholesterol
  - Mevalonate
  - Squalene
---
